Request Demo
Last update 29 Mar 2025
AEG-33773
Last update 29 Mar 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms AEG 33773, AEG33773 |
Target |
Action stimulants |
Mechanism HSP90 stimulants(Heat shock 90kDa proteins stimulants) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with AEG-33773EUCTR2009-011254-18-BG
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of AEG33773 versus Placebo in Patients with Painful Diabetic Peripheral Neuropathy - n/a
NCT00891683
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Safety and Efficacy of AEG33773 Versus Placebo in Patients With Painful Diabetic Peripheral Neuropathy
100 Clinical Results associated with AEG-33773
Login to view more data
100 Translational Medicine associated with AEG-33773
Login to view more data
100 Patents (Medical) associated with AEG-33773
Login to view more data
1
Literatures (Medical) associated with AEG-3377301 May 2010IDrugs : the investigational drugs journal
American Society for Clinical Pharmacology and Therapeutics (ASCPT)-111th annual meeting. 17-20 March 2010, Atlanta, GA, USA.
Author: Veryard, Claire
The 111th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics, held in Atlanta, included topics covering disclosures of new data in the field of pharmacokinetics and drug interactions. This conference report highlights selected presentations on pharmacokinetic studies of several investigational drugs, including evatanepag (Pfizer Inc), AEG-33773 (Aegera Therapeutics Inc), JNJ-16269110 (Johnson & Johnson Pharmaceutical Research & Development LLC), PF-3716539 (ViiV Healthcare), MK-0736 (Merck & Co Inc), a combination of Ginkgo biloba and cilostazol (Renexin SK Chemicals Co Ltd), PP-101 (Pacific Pharmaceuticals Co Ltd), ACT-178882 (Acetlion Ltd/Merck & Co Inc) and edoxaban (Daiichi Sankyo Co Ltd).
100 Deals associated with AEG-33773
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Chronic Pain | Phase 2 | United States | 01 Mar 2009 | |
| Chronic Pain | Phase 2 | Bulgaria | 01 Mar 2009 | |
| Chronic Pain | Phase 2 | Canada | 01 Mar 2009 | |
| Chronic Pain | Phase 2 | Romania | 01 Mar 2009 | |
| Diabetic peripheral neuropathy | Phase 2 | United States | 01 Mar 2009 | |
| Diabetic peripheral neuropathy | Phase 2 | Bulgaria | 01 Mar 2009 | |
| Diabetic peripheral neuropathy | Phase 2 | Canada | 01 Mar 2009 | |
| Diabetic peripheral neuropathy | Phase 2 | Romania | 01 Mar 2009 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free